West Pharmaceutical Services Inc. ($WST) Stock Forecast: Up 4.0% Today

What is West Pharmaceutical Services Inc.?

West Pharmaceutical Services, Inc. (WST) specializes in pharmaceutical packaging and delivery systems. The market for healthcare-related stocks has experienced volatility influenced by regulatory changes and industry developments.

Why is West Pharmaceutical Services Inc. going up?

WST stock is up 4.0% on Jul 10, 2025 14:46

• The rise in WST's stock price could be due to investors' growing confidence in the company's ability to manage the class action lawsuit situation.
• Initially, the announcement of investors having the chance to lead a class action lawsuit caused uncertainty and a decrease in the stock price.
• However, as more investors engage legal support to discuss their rights before the deadline, it suggests a potential positive resolution for the company, leading to the stock's upward movement.
• This scenario emphasizes the significance of monitoring legal developments and investor sentiment alongside the company's operational performance when evaluating stock fluctuations.

WST Price Chart

WST Technical Analysis

WST News

WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - West Pharmaceutical Servs ( NYSE:WST )

NEW YORK, July 06, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ( "West" or "the Company" ) WST and certain of its ...

https://www.benzinga.com/pressreleases/25/07/g46266414/wst-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-west-pharmaceutical-services-inc-

Investors in West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST - West Pharmaceutical Servs ( NYSE:WST )

NEW YORK, July 03, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ( "West Pharmaceutical Services, Inc." or the "Company" ) WST of a class action securities lawsuit.

https://www.benzinga.com/pressreleases/25/07/g46254322/investors-in-west-pharmaceutical-services-inc-should-contact-levi-korsinsky-before-july-7-2025-to-

Trending Today

Dogecoin ($DOGE) Crypto Forecast: Up 8.9% Today

Netflix Inc. ($NFLX) Stock Forecast: Down 5.1% Today

StoneCo Ltd. ($STNE) Stock Forecast: Down 7.6% Today

Regions Financial Corporation ($RF) Stock Forecast: Up 6.2% Today

Cytokinetics, Incorporated ($CYTK) Stock Forecast: Down 5.2% Today

Comerica Incorporated ($CMA) Stock Forecast: Up 5.0% Today

Astera Labs Inc ($ALAB) Stock Forecast: Up 5.5% Today

3M Company ($MMM) Stock Forecast: Down 5.3% Today

XRP ($XRP) Crypto Forecast: Up 5.8% Today

Invesco Ltd ($IVZ) Stock Forecast: Up 15.6% Today

West Pharmaceutical Services Inc. Price History

03.00.2025 - WST Stock was up 3.6%

• Investors may have perceived WST's value favorably compared to its competitor Labcorp (LH).
• The contrast between LH and WST could have positioned WST as an underestimated stock, appealing to more investors.
• This positive perception of WST's value proposition likely contributed to the bullish performance of the stock today.

24.09.2024 - WST Stock was up 17.1%

• West Pharmaceutical Services, Inc. (WST) reported adjusted EPS of $1.85, surpassing expectations and showing resilience in its financial performance.
• Despite concerns about weakness in its Proprietary Products business and unfavorable currency movements, the company managed to exceed sales expectations, leading to the bullish movement in its stock.
• Investors may be optimistic about the company's ability to navigate challenges and deliver strong results, driving the stock price higher.

24.09.2024 - WST Stock was up 19.6%

• Despite the expected weakness in the Proprietary Products business, WST experienced a strong bullish movement.
• The unfavorable currency movements might not have had as significant an impact on the stock as anticipated.
• Investors may be optimistic about other aspects of WST's business or potential positive developments that are not captured.
• The market may have reacted positively to other factors such as strong demand for healthcare products or overall market conditions.

06.05.2025 - WST Stock was up 5.5%

• The bullish movement in WST stock could be attributed to investors' optimism regarding the pending class action lawsuit.
• The reminder of the lawsuit deadline might have sparked confidence in the market, indicating that the company is taking necessary legal actions to address any potential issues.
• This proactive approach from West Pharmaceutical Services, Inc. could have reassured investors and led to increased buying interest, driving the stock price higher.
• Overall, the market's positive reaction to the news of the pending class action lawsuit reflects investor confidence in the company's ability to handle legal challenges effectively.

24.01.2025 - WST Stock was up 5.3%

• WST experienced a bullish movement due to its identification as one of the top health care stocks with considerable growth potential this month.
• The stock being oversold in the health care sector attracted investors seeking undervalued opportunities.
• The Relative Strength Index (RSI), a momentum indicator, boosted trader confidence, resulting in increased buying pressure and a rise in the stock price.
• Positive market sentiment towards the health care sector and specific company analysis likely played a role in the notable bullish movement observed in WST.

13.01.2025 - WST Stock was down 32.6%

• Despite a positive performance in West Pharmaceutical's Q4 earnings, the stock showed a drop in pre-market trading.
• The decline in margins is considered a possible factor in the bearish movement, despite an increase in revenue in the Proprietary Products segment.
• Investors seemed to place more emphasis on the margin decrease rather than the overall earnings beat, resulting in a pessimistic market outlook and the downward trend in the stock price.

25.06.2024 - WST Stock was down 8.4%

• Reported disappointing Q2 2024 earnings, with EPS of $1.52 missing estimates and revenue of $702.10 million falling short.
• Attributed the decline in performance to a decrease in demand for its products across segments, coupled with elevated customer destocking.
• The missed earnings and lowered outlook for 2024 could have led to a lack of investor confidence, resulting in a bearish movement in the stock price.
• Concerns may arise about the company's ability to drive growth and profitability in the face of challenging market conditions, leading to a sell-off of WST shares.

25.06.2024 - WST Stock was down 12.1%

• Today, West Pharmaceutical Services Inc. (WST) faced a substantial bearish movement in the stock market, potentially influenced by its Q2 earnings report:
• The company revealed an EPS of $1.51, missing estimates, and revenue of $702.1 million falling short, indicating a weaker financial performance than expected.
• The decline in Q2 profit and missed estimates likely contributed to investor concerns and the subsequent bearish market movement.
• Additionally, the impact of unfavorable currency movements on the company's top and bottom lines might have further dampened investor sentiment, resulting in the downward trend in WST stock.

10.06.2025 - WST Stock was up 4.0%

• The rise in WST's stock price could be due to investors' growing confidence in the company's ability to manage the class action lawsuit situation.
• Initially, the announcement of investors having the chance to lead a class action lawsuit caused uncertainty and a decrease in the stock price.
• However, as more investors engage legal support to discuss their rights before the deadline, it suggests a potential positive resolution for the company, leading to the stock's upward movement.
• This scenario emphasizes the significance of monitoring legal developments and investor sentiment alongside the company's operational performance when evaluating stock fluctuations.

04.03.2025 - WST Stock was down 6.5%

• Despite the positive surge in ProDex (PDEX) stock, WST experienced a bearish movement.
• The lack of indication for further gains in ProDex might have caused investors to reallocate their funds, leading to a sell-off in WST.
• Investors may have shifted focus from WST to ProDex, anticipating better returns based on the recent surge in PDEX stock price.
• This shift in market sentiment towards ProDex could have contributed to the bearish movement in WST as investors sought potentially more lucrative opportunities in the market.

22.03.2025 - WST Stock was up 5.4%

• WST had a strong bullish movement today due to expectations of strong segmental performance in the first quarter, driven by growth in pharmaceutical stabilization, biologics rebound, and contract manufacturing gains.
• The market is likely reacting positively to the potential growth and stability in the pharmaceutical sector, which is a key market for West Pharmaceutical Services.
• Investors are optimistic about the company's ability to capitalize on the increased demand for injectable drug administration solutions, especially in the current global health landscape.

13.01.2025 - WST Stock was down 35.7%

• Despite exceeding Q4 earnings expectations, West Pharmaceutical's stock experienced a decline attributed to weaker-than-anticipated guidance for 2025. This included adjusted EPS and revenue forecasts that missed consensus estimates.
• The market responded negatively to the company's reduced earnings and revenue projections for the upcoming year, resulting in a notable sell-off of WST stock.
• Investors reacted possibly due to disappointment stemming from the downward revision in West Pharmaceutical's future financial outlook. This sentiment drove the stock price lower during today's trading session.